Screener/Healthcare/Medical - Devices

BIO

Bio-Rad Laboratories, Inc.NYSE
$276.13+4.01 (+1.47%)
Mid CapHealthcareLow P/EUndervalued
$211.43
$343.12
$273.92
$276.13
EPS (TTM)$27.91
P/E Ratio9.75
Dividend Yield—
Market Cap$7.15B
Volume4K
Prev Close$272.12
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$693.2M$720.0M$26.6549.8%103.9%
Q3 '25$653.0M-$341.9M$-12.7052.6%-52.4%
Q2 '25$651.6M$317.8M$11.6753.0%48.8%
Q1 '25$585.4M$64.0M$2.2952.3%10.9%
Q4 '24$667.5M-$715.8M$-25.5751.2%-107.2%
Q3 '24$649.7M$653.2M$23.3454.8%100.5%
Q2 '24$638.5M-$2.2B$-76.2655.6%-339.2%
Q1 '24$610.8M$383.9M$13.4553.4%62.9%
Get Your Daily Market Recap